Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) Stock Short Interest Report for September

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) was the recipient of a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 55,588 shares, a drop of 63.4% from the September 15th total of 151,789 shares. Based on an average trading volume of 188,910 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the shares of the company are sold short.

Sernova Biotherapeutics Stock Down 3.3%

Shares of Sernova Biotherapeutics stock opened at $0.08 on Wednesday. The business’s fifty day moving average price is $0.08 and its two-hundred day moving average price is $0.10. Sernova Biotherapeutics has a 1-year low of $0.06 and a 1-year high of $0.14.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last released its quarterly earnings results on Thursday, September 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01).

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies designed to provide long-term treatment for chronic diseases. The company’s primary platform, the Cell Pouch System, is an implantable device intended to create a vascularized environment in the body where therapeutic cells can be placed and supported.

Sernova has focused on cell-based therapies for conditions including type 1 diabetes, hemophilia A and thyroid disease. Its approach combines the Cell Pouch System with insulin-producing islet cells, blood-clotting factor-producing cells or other therapeutic cells, with the goal of restoring biological functions that are impaired by disease.